Filing Flows › Bausch Health Companies (BHC) › Q3 2026
Bausch Health Companies (BHC) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 29, 2026
Bausch Health Companies (BHC) reported revenue of $2.9B for the third quarter 2026 (Q3 2026), +10% from a year earlier and +3% from the quarter before. Operating margin was 33.4%, net earnings $436M (14.8% of revenue).
Bausch Health Companies, Q3 2026: revenue $2.9B (+10% year over year), operating margin 33.4%, net earnings $436M, operating cash flow $814M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9B | +3% | +10% |
| Operating profit | $983M | +33% | +59% |
| Net earnings | $436M | +69% | +144% |
| Operating cash flow | $814M | +21% | +101% |
| Free cash flow | $748M | +26% | +138% |
What changed
Revenue was $2.9B in Q3 2026, up 10% year over year and up 3% from the previous quarter. Product sales was the largest line at 99% of revenue. Product sales added $0.26B year over year (up 10%), 98% of the total change.
Operating profit was $1.0B, a 33.4% margin (up 10.3 points year over year). Of the extra revenue versus Q3 2025, 140% reached operating profit, above the 23% margin then. Total costs fell 5% while revenue rose 10%. Net earnings were $0.44B, up 144% year over year. The effective tax rate was 25.3%.
Operating cash flow was $0.81B (up 101% year over year), 183% of net income including minority interests. Non-cash charges added back $0.28B of depreciation and amortization and $0.05B of share-based compensation. Capital expenditures of $0.07B left free cash flow of $0.75B.
Questions
What was Bausch Health Companies' revenue in the third quarter 2026?
Bausch Health Companies (BHC) reported revenue of $2.9B for the third quarter 2026 (Q3 2026), +10% from a year earlier and +3% from the quarter before.
Was Bausch Health Companies profitable in the third quarter 2026?
Operating profit was $983M (33.4% of revenue) and net earnings $436M.